L, M, MR A, F R, L DP, R G, V M, M G, B JR, C L, S B, Onyango N, Nyagol J, N A, M N, I N, K P, P PP, R B, de MM S, RB R, S L, R S, H S, Leoncini L.  2019.  Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases.. Blood Cancer J.. 9(12)
M, M, LZ M, J F, GM E, E R, R N, J T, DH M, Nyagol J, F W, AK B, M B, JG O.  2019.  Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types.. J Virol.. 93(16)


Chepchirchir, A, Joshua Nyagol, Jaoko W.  2018.  Cytokine expression and hypertension comobirdity in HIV/AIDS patients at Kenyatta National Hospital HIV Care Centre, Nairobi, Kenya.. Int J of Cardiovasc Res. 7(1):1-7.


I, M, A A, S M, C B, J W, E M, Onyango N, Nyagol J.  2017.  Assessment of MNCH services provided by private health care providers in Kibra Sub-county of Nairobi County. , March. :1-56., Nairobi: Kibra Private Health Care Providers Study Report; Ministry of Health Report, Kenya


Ombura, IP, Noel Onyango, Odera S, Mutua F, Joshua Nyagol.  2016.  Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya. Plos One. 10(DOI:10.1371/journal.pone.0163994)


Erick Kipkoech Rutto, Joshua Nyagol, Julius Oyugi, Samson Ndege, Noel Onyango, Chrispinus J Simiyu, Gye Boor, Winfrida Chelangat Cheriro, a Barasa Otsyula, Estambale B.  2015.  Effects of HIV-1 infection on malaria parasitemia in milo sub-location, western Kenya. BMC Res Notes. 8(303)


A, M, Nyagol J, Rogena E, Ochuk W, Kimani M, Onyango N, Pacenti L, Santopietro R, Leoncini L, W. M.  2014.  Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva.. Infect Agent Cancer.. 9(1):7-15.



Lenze D, Leoncini L, HVLCGADFGHNMST, Ott G, Palatini J PRRSCCMSMEAR.  2011.  The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.. Leukemia. . 25(12):1869-1876.
Lenze D, Leoncini L, HVLCGADFGHMST, Nyagol J, Ott G PPRRSCCMSJMEA.  2011.  The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.. Leukemia. 25(12):1869-1876.


ucci E, Onnis A, CDFIGCCMMGFA, Cantisani R, Nyagol J MIOSBLLWRMK.  2010.  B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.. International Journal of cancer. 126(6):1316-1326.


van van Leucci E, Cocco M, ODFCBRAGPC, van Nyagol J, Byakika B LTKLSPHL.  2008.  MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.. Journal of Pathology. 216(4):440-450.


De Falco G, Leucci E, LPPPCPPOCDAG, Nyagol J, Mwanda W BHPTSGLCMSP.  2007.  Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.. Blood. 110(4):1301-1307.


de Nyagol J, Nyong'o A, BMCSMMSBLKLLBLM.  2006.  Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer.. Analytical Quantitative Cytology Histology. 28(2):97-103.
Nyagol J, Leucci E, ODFTSTPPAGCF, Santopietro R, Spina D GMLPLGPLSF.  2006.  The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis.. Cancer Biology Therapy. 5(6):684-690.


de Bellan C, Lazzi S, HPSANSMNMT, Lazure T, Pileri SA RSTLMHPL.  2005.  Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.. Blood. 106(3):1031-1036.

UoN Websites Search